The official journal of the Japanese Breast Cancer Society, Breast Cancer publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research. It develops a new focus and new perspectives for all who are concerned with breast cancer. Breast Cancer presents original articles describing clinical, epidemiological studies and laboratory investigations regarding breast cancer and related diseases. It features editorials, review articles, original articles, case reports, and short papers. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.
Breast Cancer
Description
Identifiers
ISSN | 1340-6868 |
e-ISSN | 1880-4233 |
DOI | 10.1007/12282.1880-4233 |
Publisher
Springer Japan
Additional information
Data set: Springer
Articles
Breast Cancer > 2019 > 26 > 6 > 784-791
Background Triple-negative breast cancer (TNBC), defined by lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is characterized by early recurrence of disease and poor survival. Objective Here, we sought to identify genes associated with TNBC that could provide new insight into gene dysregulation in TNBC and, at the same...
Breast Cancer > 2019 > 26 > 6 > 719-728
Purpose Physical activity and lower BMI have shown benefit for breast cancer survival, but the association between these factors, pathologic complete response (pCR), and chemotherapy completion is not clear. We evaluated whether BMI and physical activity are associated with pCR and chemotherapy completion during neoadjuvant breast cancer treatment. Methods We conducted a retrospective case–control...
Breast Cancer > 2019 > 26 > 6 > 776-783
Background Transgelin-2 is an actin-binding protein that is widely expressed in various tissues and organs of the body, and reportedly may participate in the development and progression of multiple cancers. However, the clinical significance of transgelin-2 still remains controversial. We, therefore, aimed to determine the expression of transgelin-2 in breast cancer as well as its correlation with...